neurodegenerative diseases Archives

NeuroSense Completes Dosing of Last Patient in the Double-Blind Segment of Phase 2b ALS Trial: Topline Clinical Efficacy Results Expected December 2023

3 min read

NeuroSense Completes Dosing of Last Patient in the Double-Blind Segment of Phase 2b ALS Trial: Topline Clinical Efficacy Results Expected December 2023

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced it has completed...

neurodegenerative diseases

NeuroSense Completes Dosing of Last Patient in the Double-Blind Segment of Phase 2b ALS Trial: Topline Clinical Efficacy Results Expected December 2023

ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products

You may have missed

IMA to Organize Conference on “Multispecialities Cardio Reno Metabolic & HF in Women” Tomorrow

Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires

Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas

WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad

NeuroSense Completes Dosing of Last Patient in the Double-Blind Segment of Phase 2b ALS Trial: Topline Clinical Efficacy Results Expected December 2023

ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products

You may have missed

IMA to Organize Conference on “Multispecialities Cardio Reno Metabolic & HF in Women” Tomorrow

Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires￼

Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas￼

WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad

Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires

Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas